Want to join the conversation?
$PM launched a Reduced-Risk Product, iQOS, in Switzerland in August with an initial focus on 5 major cities and began the national expansion of iQOS in Japan in September. "We continue to progress with the commercialization and clinical assessment of our Reduced-Risk Product, iQOS," said Andre Calantzopoulos, CEO.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?